Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-09-09

Clinical Trial Update: A Mono-center Study in Healthy Volunteers on the Comparative Bioavailability of Pletal 100 mg Tablets and a New Pletal 100 mg Orodispersible Tablet (ODT), This Latter in Fasting Conditions With and Without Water and Under Fed Conditions [Phase 1]

View source ↗

Summary

Phase 1 bioavailability study comparing Pletal 100 mg tablet with a new Pletal 100 mg orodispersible tablet under fasting (with and without water) and fed condi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pletal (cilostazol)

Snippet

Sponsor: Otsuka Frankfurt Research Institute GmbH | Conditions: Intermittent Claudication | Phase 1 | Status: COMPLETED